Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

140.34
+2.351.70%
Post-market: 138.89-1.4500-1.03%19:59 EDT
Volume:18.57M
Turnover:2.61B
Market Cap:56.03B
PE:-17.53
High:144.20
Open:134.10
Low:133.86
Close:137.99
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:0.60
T/O Rate:5.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.29
PE(LYR):-19.33

Loading ...

The "Holy Grail" Of Cancer Treatment? Moderna's Melanoma MRNA Vaccine Succeeds In Phase 3 Trial

Options & Short Sell
·
Aug 19

Moderna Shares More than Double Premarket; Last up 103%

THOMSON REUTERS
·
Aug 19

Stocks to Watch: Oracle, SK Hynix, Moderna, Unitree

Dow Jones
·
Aug 19

US Stocks-Wall St Futures Flat After Tech Rout; Iran Tensions, Retail Earnings in Focus

Reuters
·
Aug 19

Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 19

U.S. Stocks on the MOVE-Estee Lauder, Target, Analog Devices

Reuters
·
Aug 19

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Moderna Vaccine Cuts Recurrence and Spread of High-Risk Melanoma, Raising New Treatment Hope

Reuters
·
Aug 19

Moderna jumps 54% to $97.52 after Phase 3 INTerpath-001 trial met endpoints

TIPRANKS
·
Aug 19

Moderna Shares Extend Gains; Last up 46.9% Premarket

THOMSON REUTERS
·
Aug 19

Movement Alert|Moderna, Inc. Rises 8.74% in Pre-Market Trading, Multiple Catalysts Including Positive Melanoma Trial and Flu Vaccine Retail Launch

Market Focus
·
Aug 19

Merck, Moderna Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Merck: Co, Moderna Announce Positive Results from Phase 3 Interpath-001 Trial for Patients with Completely Resected Stage Iib-Iv Melanoma

THOMSON REUTERS
·
Aug 19

Merck: Co, Moderna Will Engage with Regulators on Filing Submissions for Intismeran Autogene in Combination with Keytruda

THOMSON REUTERS
·
Aug 19

Trump Picks White House Adviser Heidi Overton to Run FDA, Source Says

Reuters
·
Aug 19

Moderna (MRNA) Stock Looks Pricey After A 126% Return Yet Sales Stay Strong

Simply Wall St.
·
Aug 17

Moderna (MRNA) Starts Ebola Vaccine Trial As Fair Value Questions Persist

Simply Wall St.
·
Aug 16